Paired with Roche's HPV testing offerings, the deal will expand its cervical cancer testing capabilities.
The German-based company expects to file its test for FFPE within the next few months, and to start a clinical trial for its cytology test by mid-year.
The funds will be used to support clinical trials and commercialization efforts, as well as US regulatory clinical trials for a PMA submission for its CINtec Plus Cytology platform.
The CTAF recommendation is "an important decision-making resource for clinicians and patients," the firm's CEO said.
Patents awarded to GeneNews, US Army, Aisin Seiki, MTM Laboratories, and USC.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.